Use of carnitine therapy in selected cases of male factor infertility: A double-blind crossover trial

Fertility and Sterility

Volumn 79, Issue 2, 2003, Pages 292-300

  Lenzi, Andrea ^a   Lombardo, Francesco ^a   Sgrò, Paolo ^a   Salacone, Pietro ^a   Caponecchia, Luisa ^a   Dondero, Franco ^a   Gandini, Loredana ^a  

^a SAPIENZA UNIVERSITY OF ROME   (Italy)

Author keywords

Fertility; L carnitine; Male infertility; Mitochondria; Oligozoospermia; Semen; Sperm motility; Spermatozoa; Therapy

Indexed keywords

CARNITINE;

ADULT; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CROSSOVER PROCEDURE; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; HUMAN; HUMAN CELL; MAJOR CLINICAL STUDY; MALE; MALE INFERTILITY; METHODOLOGY; MORPHOLOGY; PATIENT SELECTION; PRIORITY JOURNAL; SPERM; SPERMATOZOON DENSITY; SPERMATOZOON MOTILITY; STATISTICAL SIGNIFICANCE; VELOCITY;

EID: 0037309210     PISSN: 00150282     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0015-0282(02)04679-4     Document Type: Article

References (43)

1. Carlsen E., Giwercman A., Keiding N., Skakkebaek N.E. Evidence for decreasing quality of semen during the past 50 years. Br Med J. 305:1992;609-613.
2. Auger J., Kunstmann J.M., Czyglik F., Jouannet P. Decline in semen quality among fertile men in Paris during the past 20 years. N Engl J Med. 332:1995;281-285.
3. Gandini L., Lombardo F., Culasso F., Dondero F., Lenzi A. Myth and reality of the decline in semen quality an example of the relativity of data interpretation . J Endocrinol Invest. 23:2000;402-411.
4. Swan S.H., Elkin E.P., Fenster L. The question of declining sperm density revisited, an analysis of 101 studies published 1934-1996. Environ Health Perspect. 108:2000;961-966.
5. WHO manual for the standardized investigation, diagnosis and management of the infertile male. Rowe P, Comhaire F, Hargreave B, Mahmoud A, eds. Cambridge: Cambridge University Press: 2000:37-60.
6. Nieschlag E. Care for the infertile male. Clin Endocrinol. 38:1993;123-133.
7. O'Donovan P.A., Vandekerckhove P., Lilford R.J., Hughes E. Treatment of male infertility Is it effective? Review and Meta-analyses of published randomized controlled trials . Hum Reprod. 8:1993;1209-1222.
8. Kamischke A., Nieschlag E. Analysis of medical treatment of male infertility. Hum Reprod. 14:(Suppl 1):1999;1-23.
9. Adamopoulos D.A. Present and future therapeutic strategies for idiopathic oligozoospermia. Int J Androl. 23:2000;320-331.
10. Oehninger S. Clinical and laboratory management of male infertility an opinion on its current status . J Androl. 21:2000;814-821.
11. The effect of clomiphene citrate and vitamin C for male infertility a randomized trial . Brit J Urol. 54:1982;780-784.
12. The effect of mesterolone versus vitamin C for male infertility a randomized trial . Brit J Urol. 56:1984;740-744.
13. Knuth U.A., Honingl W., Bals-Pratsch M., Schleicher G., Nieschlag E. Treatment of severe oligozoospermia with hCG/hMG, a placebo-controlled, double blind trial. J Clin Endoc Metab. 65:1987;1081-1087.
14. Mesterolone and idiopathic male infertility, a double blind study. Int J Androl. 12:1989;254-259.
15. A double-blind trial of clomiphene citrate for the treatment of idiopathic male infertility. Int J Androl. 15:1992;299-307.
16. Lenzi A., Culasso F., Gandini L., Lombardo, Dondero F. Placebo-controlled, double-blind, cross-over trial of glutathione therapy in male infertility. Hum Reprod. 8:1993;1657-1662.
17. Keck C., Behre H.M., Jockenhövel F., Nieschlag E. Ineffectiveness of kallikrein in treatment of idiopathic male infertility a double-blind, randomized, placebo-controlled trial . Hum Reprod. 9:1994;325-329.
18. Kessopoulou E., Powers H.J., Sharma K.K., Pearson M.J., Russell J.M., Cooke I.D., et al. A double blind randomized placebo controlled trial using the antioxidant vitamin E to treat oxygen species associated male infertility. Fertil Steril. 64:1995;825-831.
19. Vandekerckhove P., Lilford R., Hughes E. The medical treatment of idiopathic oligo/asthenospermia, androgens (mesterolone or testosterone) versus placebo or no treatment. Lilford R., Hughes E., Vandekerckhove P. Subfertility module of the Cochrane database of systematic reviews. 1996;The Cochrane Library, Update Software, Oxford.
20. Vandekerckhove P., Lilford R., Hughes E. The medical treatment of oligo/asthenospermia, anti-oestrogens (clomiphene or tamoxifen) versus placebo or no treatment. Lilford R., Hughes E., Vandekerckhove P. Subfertility module of the Cochrane database of systematic reviews. 1998;The Cochrane Library, Update Software, Oxford.
21. Kamischke A., Behre H.M., Bergmann M., Simoni M., Schafer T., Nieschlag E. Recombinant human follicle stimulating hormone for treatment of male idiopathic infertility a randomized, double-blind, placebo-controlled, clinical trial . Hum Reprod. 13:1998;596-603.
22. Rolf C., Cooper T.G., Yeung C.H., Nieschlag E. Antioxidant treatment of patients with asthenozoospermia a moderate oligoasthenozoospermia with high-dose vitamin C and vitamin E a randomized, placebo-controlled, double blind study . Hum Reprod. 14:1999;1028-1033.
23. Lenzi A., Picardo M., Gandini L., Lombardo F., Terminali O., Passi S., et al. Glutathione treatment of dyspermia effect on the lipoperoxidation process . Hum Reprod. 9:1994;2044-2050.
24. Lenzi A., Picardo M., Gandini L., Dondero F. Lipids of sperm plasma membrane from polyunsaturated fatty acid considered as markers of sperm function to possible scavenger therapy . Hum Reprod Update. 2:1996;246-256.
25. Lenzi A., Gandini L., Picardo M. A rationale for glutatione therapy. In debate on is antioxidant therapy a promising strategy to improve human reproduction? Hum Reprod. 13:1998;1419-1422.
26. Frenkel R.A., Mc Garry J.D. Carnitine biosyntesis, metabolism and function. [Italian edition]. 1984;Academic Press, New York.
27. Peluso G., Nicolai R., Reda E., Benatti P., Barbarisi A., Calvani M. Cancer and anticancer therapy-induced modifications on metabolism mediated by carnitine system. J Cell Physiol. 182:2000;339-350.
28. Arduini A. Carnitine and its acyl esters as secondary antioxidants? Am Heart J. 123:1992;1726-1727.
29. Costa M., Canale D., Filicori M., D'Iddio S., Lenzi A. L-carnitine in idiopathic asthenozoospermia, a multicenter study. Andrologia. 26:1994;155-159.
30. Vicari E., Calogero A.E. Effects of treatment with carnitines in infertile patients with prostato-vesiculo-epididymitis. Hum Reprod. 16:2001;2338-2342.
31. Laboratory manual for the examination of human semen and semen-cervical mucus interaction. 4th ed: 1999; Cambridge University Press, Cambridge.
32. Soufir J.C., Marson J., Jouannet P. Free L-carnitine in human seminal plasma. Int J Androl. 4:1981;388-397.
33. Aitken R.J., Clarkson J.S., Fishel S. Generation of reactive oxygen species, lipid peroxidation and human sperm function. Biol Reprod. 41:1989;183-197.
34. Gandini L., Menditto A., Chiodo F., Lenzi A. Italian pilot study for an external quality control scheme in semen analysis and antisperm antibiotics detection. Int J Androl. 23:2000;1-3.
35. Lenzi A. Computer-aided semen analysis (CASA) 10 years later, a test-bed for the European scientific andrological community. Int J Androl. 20:1997;1-2.
36. Dondero F., Gandini L., Lombardo F., Salacone P., Caponecchia L., Lenzi A. Antisperm antibody detection 1. Methods and standard protocol . Am J Reprod Immunol. 38:1997;218-223.
37. Bolton S. Pharmaceutical statistics practical and clinical application. 1997;410-415 Marcell Dekker, New York.
38. Nieschlag E., Leifke E. Empirical therapies for male idiopathic infertility. Nieschlag E., Behre G. Andrology: male reproductive health and dysfunction. 1997;313-324 Springer Verlag, Berlin.
39. Ruiz-Pesini E., Alvarez E., Enriquez J.A., Lopez-Perez M.J. Association between seminal plasma carnitine and mitochondrial enzymatic activities. Int J Androl. 24:2001;335-340.
40. Comhaire F. Clinical andrology from evidence-base to ethics. The "E" quintet in clinical andrology . Hum Reprod. 15:2000;2067-2071.
41. Radford J.A. Is prevention of sterility possible in men? Ann Oncol. 11:(Suppl 3):2000;173-174.
42. Sandlow J.I. Shattering the myths about male infertility. Treatment of male factors may be more successful and cost-effective than you think. Postgrad Med. 107:2000;235-239.
43. Falcone T. What the internist needs to know about infertility. Cleve Clin J Med. 68:2001;65-72.